Penalty Amount
$29,600,000
Attorney General Phil Weiser joined a bipartisan coalition of 48 states and territories in announcing a $29.6 million settlement with Glenmark Pharmaceuticals. The settlement resolves allegations that Glenmark participated in a widespread conspiracy to inflate prices, reduce competition, and restrain trade for numerous generic prescription drugs. Glenmark also agreed to cooperate in ongoing multistate litigation and implement internal reforms.
Glenmark must pay $29.6 million, cooperate in ongoing multistate litigation against other defendants, and implement internal reforms to strengthen antitrust compliance and promote fair competition.
In-house legal teams should review vendor agreements with generic drug manufacturers for any clauses that could facilitate price-fixing or market allocation, such as information-sharing provisions, pricing coordination terms, or non-compete clauses. Customer contracts with pharmacies and distributors should be examined for any pricing mechanisms that might be influenced by collusion. Additionally, internal compliance programs and employee training materials should be updated to emphasize antitrust law requirements and the prohibition of communications with competitors regarding pricing or market division.
Entity
Glenmark Pharmaceuticals
Industry
Healthcare"Glenmark Pharmaceuticals"
"$29.6 million settlement"
"antitrust laws"
"conspiracy to inflate prices, reduce competition, and restrain trade"
"bipartisan coalition of 48 states and territories"
$29.6M
Minnesota Attorney General Keith Ellison joined a 48-state coalition in a $29.6 million settlement with generic-drug manufacturer Glenmark to resolve allegations of a widespread conspiracy to artificially inflate and manipulate prices, reduce competition, and restrain trade for numerous generic prescription drugs. The settlement requires Glenmark to cooperate in ongoing multistate lawsuits and implement internal reforms to ensure compliance with antitrust laws.
$29.6M
Oregon Attorney General Dan Rayfield and a bipartisan coalition of states reached a $29.6 million settlement with Glenmark, a generic drug manufacturer accused of conspiring with other pharmaceutical companies to inflate prices and limit competition for numerous generic prescription drugs. The settlement requires Glenmark to cooperate in ongoing multistate litigations and implement internal reforms to ensure fair competition and antitrust compliance.
The Colorado Domestic Violence Fatality Review Board’s 2026 report describes domestic violence fatalities in Colorado and identifies trends and prevention opportunities. It is a public report, not a privacy enforcement action, and the release announces no penalty or remedy.
Colorado, the FTC, and a bipartisan group of state attorneys general filed suit to block PlayPower’s proposed acquisition of Burke, alleging the merger would reduce competition in the commercial playground equipment market. They ask the court to permanently enjoin the merger and award costs, attorneys’ fees, and other appropriate relief.
Colorado Attorney General Phil Weiser led a multistate coalition in filing a notice in Character Technologies, Inc.’s bankruptcy, citing concerns about the company’s safety and privacy practices and sensitive chatbot conversations involving children and adults. The filing seeks protections in any sale or transfer of the company’s business or assets; no penalty or final remedy is reported.
Colorado Attorney General Phil Weiser issued a public advisory explaining that e-bikes must meet statutory class requirements and that retailers must clearly disclose what they are selling. The advisory warns that marketing a higher-powered electric vehicle as an e-bike without required disclosures may violate state consumer protection law; it announces no penalty or binding remedy.